Appropriateness of dabigatran dosing in patients with nonvalvular atrial fibrillation (NVAF): A retrospective study conducted in a tertiary care university hospital in the eastern province of Saudi Arabia

BACKGROUND: Establishment of thromboembolism prevention remains a challenge despite the widespread consensus that thromboprophylaxis safely reduces patient morbidity and mortality. Dabigatran is a nonvitamin K antagonist oral anticoagulant (NOAC) which reduces the risk of thromboembolism. Proper dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Alali, Nasser, Mahmoud, Mahmoud Hassan, Alharbi, Mousa Ayesh, Ghazal, Sami Nimer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555874/
https://www.ncbi.nlm.nih.gov/pubmed/31198397
http://dx.doi.org/10.1016/j.jsha.2019.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555874/
https://www.ncbi.nlm.nih.gov/pubmed/31198397
http://dx.doi.org/10.1016/j.jsha.2019.05.002

Ejemplares similares